Idaho Falls, ID – October 21st, 2025 – International Isotopes, Inc. (OTCQB: INIS) (“INIS” or the “Company”), together with American Fuel Resources LLC (“AFR”), has submitted an application to the U.S. Nuclear Regulatory Commission (NRC) requesting consent to transfer INIS’s New Mexico license to AFR’s wholly owned subsidiary, Green Salt Products LLC.
This filing represents an important procedural step under the previously announced agreement for AFR to acquire INIS’s depleted uranium deconversion and fluorine processing assets for $12.5 million in cash at closing. The NRC’s review and consent process is expected to continue through the remaining period of the transaction’s Outside Date.
This application does not constitute final approval of the transfer and NRC consent does not constitute a license transfer. The closing of the transaction remains subject to NRC’s review process, receipt of required regulatory consents, satisfaction of customary closing conditions, and payment of financial considerations.
****
About International Isotopes Inc.
International Isotopes Inc. (INIS), established in 1995, with its headquarters in Idaho Falls, ID, USA, manufactures a wide range of radioisotope-focused products. INIS manufactures and supplies generic sodium iodide I-131 radio-pharmaceutical drug product for hyperthyroidism and thyroid cancer. INIS provides contract manufacturing of various drug products as well as radioisotope API supply for 3rd party theranostics clients INIS manufactures and distributes a complete line of calibration and reference standards for nuclear pharmacies and SPECT/PET imaging systems as well as industrial calibration standards under its RadQual brand. The Company also manufactures Cobalt-60 sealed source products. For more information, visit intisoid.com.
Safe Harbor Statements
Certain statements in this press release are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements with respect to the Company’s future growth expectations. Information contained in such forward-looking statements is based on current expectations and is subject to change. These statements involve a number of risks, uncertainties and other factors that could cause actual results, performance, or achievements of International Isotopes Inc. to be materially different from any future results, performance or achievements of the Company expressed or implied by these forward-looking statements. Other factors, which could materially affect such forward-looking statements, can be found in the Company’s filings with the Securities and Exchange Commission at www.sec.gov, including its Annual Report on Form 10-K for the year ended December 31, 2024. Investors, potential investors, and other readers are urged to consider these factors carefully in evaluating the forward- looking statements and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements made herein are only made as of the date of this press release and International Isotopes, Inc. and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.
International Isotopes Contact:
IR@intisoid.com
intisoid.com
208.524.5300